Measuring HIV Acquisitions Among Partners of Key Populations: Estimates From HIV Transmission Dynamic Models.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 Jan 2024
Historique:
medline: 5 1 2024
pubmed: 5 1 2024
entrez: 5 1 2024
Statut: ppublish

Résumé

Key populations (KPs), including female sex workers (FSWs), gay men and other men who have sex with men (MSM), people who inject drugs (PWID), and transgender women (TGW) experience disproportionate risks of HIV acquisition. The UNAIDS Global AIDS 2022 Update reported that one-quarter of all new HIV infections occurred among their non-KP sexual partners. However, this fraction relied on heuristics regarding the ratio of new infections that KPs transmitted to their non-KP partners to the new infections acquired among KPs (herein referred to as "infection ratios"). We recalculated these ratios using dynamic transmission models. One hundred seventy-eight settings (106 countries). Infection ratios for FSW, MSM, PWID, TGW, and clients of FSW were estimated from 12 models for 2020. Median model estimates of infection ratios were 0.7 (interquartile range: 0.5-1.0; n = 172 estimates) and 1.2 (0.8-1.8; n = 127) for acquisitions from FSW clients and transmissions from FSW to all their non-KP partners, respectively, which were comparable with the previous UNAIDS assumptions (0.2-1.5 across regions). Model estimates for female partners of MSM were 0.5 (0.2-0.8; n = 20) and 0.3 (0.2-0.4; n = 10) for partners of PWID across settings in Eastern and Southern Africa, lower than the corresponding UNAIDS assumptions (0.9 and 0.8, respectively). The few available model estimates for TGW were higher [5.1 (1.2-7.0; n = 8)] than the UNAIDS assumptions (0.1-0.3). Model estimates for non-FSW partners of FSW clients in Western and Central Africa were high (1.7; 1.0-2.3; n = 29). Ratios of new infections among non-KP partners relative to KP were high, confirming the importance of better addressing prevention and treatment needs among KP as central to reducing overall HIV incidence.

Sections du résumé

BACKGROUND BACKGROUND
Key populations (KPs), including female sex workers (FSWs), gay men and other men who have sex with men (MSM), people who inject drugs (PWID), and transgender women (TGW) experience disproportionate risks of HIV acquisition. The UNAIDS Global AIDS 2022 Update reported that one-quarter of all new HIV infections occurred among their non-KP sexual partners. However, this fraction relied on heuristics regarding the ratio of new infections that KPs transmitted to their non-KP partners to the new infections acquired among KPs (herein referred to as "infection ratios"). We recalculated these ratios using dynamic transmission models.
SETTING METHODS
One hundred seventy-eight settings (106 countries).
METHODS METHODS
Infection ratios for FSW, MSM, PWID, TGW, and clients of FSW were estimated from 12 models for 2020.
RESULTS RESULTS
Median model estimates of infection ratios were 0.7 (interquartile range: 0.5-1.0; n = 172 estimates) and 1.2 (0.8-1.8; n = 127) for acquisitions from FSW clients and transmissions from FSW to all their non-KP partners, respectively, which were comparable with the previous UNAIDS assumptions (0.2-1.5 across regions). Model estimates for female partners of MSM were 0.5 (0.2-0.8; n = 20) and 0.3 (0.2-0.4; n = 10) for partners of PWID across settings in Eastern and Southern Africa, lower than the corresponding UNAIDS assumptions (0.9 and 0.8, respectively). The few available model estimates for TGW were higher [5.1 (1.2-7.0; n = 8)] than the UNAIDS assumptions (0.1-0.3). Model estimates for non-FSW partners of FSW clients in Western and Central Africa were high (1.7; 1.0-2.3; n = 29).
CONCLUSIONS CONCLUSIONS
Ratios of new infections among non-KP partners relative to KP were high, confirming the importance of better addressing prevention and treatment needs among KP as central to reducing overall HIV incidence.

Identifiants

pubmed: 38180739
doi: 10.1097/QAI.0000000000003334
pii: 00126334-202401011-00007
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e59-e69

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

K.M.M. reports payments from Pfizer for teaching, outside the submitted work. The remaining authors have no conflicts of interest to disclose.

Références

Garnett GP. Reductions in HIV incidence are likely to increase the importance of key population programmes for HIV control in sub-Saharan Africa. J Int AIDS Soc. 2021;24(suppl 3):e25727.
Baral S, Rao A, Sullivan P, et al. The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment. Lancet HIV. 2019;6:e632–e638.
Nachega JB, Musoke P, Kilmarx PH, et al. Global HIV control: is the glass half empty or half full? Lancet HIV. 2023;10:e617–e622.
Joint United Nations Programme on HIV/AIDS. In Danger: UNAIDS Global AIDS Update 2022. Geneva, Switzerland: UNAIDS; 2022.
Korenromp E, Sabin K, Stover J, et al. New HIV infections among key populations and their partners in 2010 and 2022, by world region—a multi-sources estimation. 2023 [epub ahead of print].
Patel P, Borkowf CB, Brooks JT, et al. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28:1509–1519.
Stover J, Glaubius R, Teng Y, et al. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030. PLoS Med. 2021;18:e1003831.
Brown T, Peerapatanapokin W. The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia. Sex Transm Infect. 2004;80(suppl 1):i19–i24.
Maheu-Giroux M, Vesga JF, Diabaté S, et al. Changing dynamics of HIV transmission in cote d’Ivoire: modeling who acquired and transmitted infections and estimating the impact of past HIV interventions (1976–2015). J Acquir Immune Defic Syndr. 2017;75:517–527.
Stone J, Mukandavire C, Boily M-C, et al. Estimating the contribution of key populations towards HIV transmission in South Africa. J Int AIDS Soc. 2021;24:e25650.
Stevens O, Anderson R, Stover J, et al. Comparison of empirically-derived and model-based estimates of key population HIV incidence and the distribution of new infections by population group in sub-Saharan Africa. 2023 [epub ahead of print].
The Global Fund. The Global Fund Webpage. 2023. Available at: https://www.theglobalfund.org/en/. Accessed July 27, 2023.
The HIV Prevention Trials Network. HPTN Modelling Centre Webpage. 2023. Available at: https://hptnmodelling.org/. Accessed July 27, 2023.
Kerr CC, Stuart RM, Gray RT, et al. Optima: a model for HIV epidemic analysis, program prioritization, and resource optimization. J Acquir Immune Defic Syndr. 2015;69:365–376.
van Schalkwyk C, Dorrington RE, Seatlhodi T, et al. Modelling of HIV prevention and treatment progress in five South African metropolitan districts. Sci Rep. 2021;11:5652.
Bershteyn A, Gerardin J, Bridenbecker D, et al. Implementation and applications of EMOD, an individual-based multi-disease odelling platform. Pathog Dis. 2018;76:fty059.
Mishra S, Ma H, Schwartz S, et al. Epidemic Impact of Sustained Viremia Among Female Sex Workers in Southern Africa. Seattle, WA: CROI; 2019.
Silhol R, Baral S, Bowring AL, et al. Quantifying the evolving contribution of HIV interventions and key populations to the HIV epidemic in Yaoundé, Cameroon. J Acquir Immune Defic Syndr. 2021;86:396–405.
Silhol R, Maheu-Giroux M, Soni N, et al. Assessing the potential population-level impacts of HIV self-testing distribution among key populations in Côte d’Ivoire, Mali, and Senegal: a mathematical modelling analysis. medRxiv. 2023 [epub ahead of print]. doi: 10.1101/2023.08.23.23294498.
doi: 10.1101/2023.08.23.23294498
Maheu-Giroux M, Diabaté S, Boily MC, et al. Cost-effectiveness of accelerated HIV response scenarios in Côte d’Ivoire. J Acquir Immune Defic Syndr. 2019;80:503–512.
Lowndes CM, Alary M, Labbé AC, et al. Interventions among male clients of female sex workers in Benin, West Africa: an essential component of targeted HIV preventive interventions. Sex Transm Infections. 2007;83:577–581.
UNAIDS. AIDSInfo. 2021. Available at: https://aidsinfo.unaids.org/. Accessed November 9, 2021.
Stannah J, Soni N, Lam JKS, et al. Trends in HIV testing, the treatment cascade, and HIV incidence among men who have sex with men in Africa: a systematic review and meta-analysis. Lancet HIV. 2023;10:e528–e542.
Stannah J, Dale E, Elmes J, et al. HIV testing and engagement with the HIV treatment cascade among men who have sex with men in Africa: a systematic review and meta-analysis. Lancet HIV. 2019;6:e769–e787.
Hodgins C, Stannah J, Kuchukhidze S, et al. Population sizes, HIV prevalence, and HIV prevention among men who paid for sex in sub-Saharan Africa (2000–2020): a meta-analysis of 87 population-based surveys. PloS Med. 2022;19:e1003861.
Booton RD, Mitchell KM, Stannah J, et al. Model Based Comparison of the Contribution of Key Populations to HIV Epidemics. Seattle, WA: CROI; 2021.
Rousseau E, Katz AWK, O’Rourke S, et al. Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya. PloS One. 2021;16:e0258542.
Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376:268–284.

Auteurs

Romain Silhol (R)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
HIV Prevention Trials Network Modelling Centre, Imperial College London, London, United Kingdom.

Rebecca L Anderson (RL)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.

Oliver Stevens (O)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.

James Stannah (J)

Department of Epidemiology and Biostatistics, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montréal, Quebec, Canada.

Ross D Booton (RD)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.

Stefan Baral (S)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Dobromir Dimitrov (D)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.

Kate M Mitchell (KM)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
HIV Prevention Trials Network Modelling Centre, Imperial College London, London, United Kingdom.
Department of Nursing and Community Health, Glasgow Caledonian University London, London, United Kindom.

Deborah Donnell (D)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.

Anna Bershteyn (A)

Department of Population Health, New York University Grossman School of Medicine, New York, New York.

Tim Brown (T)

Research Program, East-West Center, Honolulu, HI.

Sherrie L Kelly (SL)

Burnet Institute, Melbourne, Victoria, Australia.

Hae-Young Kim (HY)

Department of Population Health, New York University Grossman School of Medicine, New York, New York.

Leigh F Johnson (LF)

Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.

Mathieu Maheu-Giroux (M)

Department of Epidemiology and Biostatistics, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montréal, Quebec, Canada.

Rowan Martin-Hughes (R)

Burnet Institute, Melbourne, Victoria, Australia.

Sharmistha Mishra (S)

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Wiwat Peerapatanapokin (W)

Research Program, East-West Center, Honolulu, HI.

Jack Stone (J)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

John Stover (J)

Avenir Health, Glastonbury, CT.

Yu Teng (Y)

Avenir Health, Glastonbury, CT.

Peter Vickerman (P)

Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Sonia Arias Garcia (SA)

Data for Impact Division, UNAIDS, Geneva, Switzerland; and.

Eline Korenromp (E)

Data for Impact Division, UNAIDS, Geneva, Switzerland; and.

Jeffrey W Imai-Eaton (JW)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA.

Marie-Claude Boily (MC)

MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom.
HIV Prevention Trials Network Modelling Centre, Imperial College London, London, United Kingdom.

Classifications MeSH